A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue

This publication has 20 references indexed in Scilit:

• Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial
  The Lancet Infectious Diseases, 2010
• Thousands of chemical starting points for antimalarial lead identification
  Nature, 2010
• Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes
  Malaria Journal, 2010
• Effect of Antimalarial Drugs onPlasmodium falciparumGametocytes
  The Journal of Infectious Diseases, 2009
• Development of an Alamar Blue™ Viability Assay in 384-Well Format for High Throughput Whole Cell Screening of Trypanosoma brucei brucei Bloodstream Form Strain 427
  The American Journal of Tropical Medicine and Hygiene, 2009
• In silicoactivity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
  Proceedings of the National Academy of Sciences, 2008
• Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility
  Nature Chemical Biology, 2008
• Trioxaquines Are New Antimalarial Agents Active on All Erythrocytic Forms, Including Gametocytes
  Antimicrobial Agents and Chemotherapy, 2007
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays
  SLAS Discovery, 1999
• The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin.
  1994